Evidence-based guide on combining green tea extract or EGCG with the MOTS-c mitochondrial peptide. Covers interaction mechanisms, dose-separation strategies, hepatotoxicity risk, and monitoring recommendations.
MOTS-c and quercetin share overlapping AMPK and mitochondrial pathways. Learn whether combining them is safe, how quercetin's CYP3A4 inhibition may affect peptide metabolism, and what monitoring to request from your prescriber.
Expert analysis of the MOTS-c and St. John's Wort interaction, covering CYP3A4 induction, pharmacokinetic concerns, dose-separation strategies, and monitoring recommendations.
Evidence-based guide on combining vitamin B12 with MOTS-c mitochondrial peptide. Covers interaction mechanisms, dose-separation windows, monitoring protocols, and safety considerations.
Evidence-based guide to taking zinc alongside the mitochondrial peptide MOTS-c. Covers pharmacokinetic and pharmacodynamic interactions, dose-separation windows, testosterone pathway effects, copper balance risks, and monitoring recommendations.
Clinical guide to combining alpha-lipoic acid with Mounjaro (tirzepatide). Covers interaction mechanisms, hypoglycemia risk, thyroid effects, dose-separation strategies, and monitoring protocols.
Evidence-based guide on combining ashwagandha with Mounjaro (tirzepatide). Covers pharmacokinetic and pharmacodynamic interactions, cortisol effects, thyroid considerations, dose-separation timing, and monitoring recommendations.
Berberine and Mounjaro (tirzepatide) both lower blood sugar through different mechanisms. Learn about the pharmacokinetic and pharmacodynamic interaction risks, safe dose-separation windows, and monitoring protocols.
Creatine and Mounjaro (tirzepatide) can generally be taken together, but creatinine elevation from creatine supplementation may complicate renal monitoring. Here's what clinicians and patients need to know.
Clinical guide to taking ginseng supplements while on Mounjaro (tirzepatide). Covers pharmacodynamic interactions, hypoglycemia risk, anticoagulant effects, dose-separation windows, and monitoring.
Evidence-based guide on combining glutathione supplements with Mounjaro (tirzepatide). Covers interaction mechanisms, dose-separation strategies, liver enzyme monitoring, and clinical recommendations.
Evidence-based guide on taking melatonin with Mounjaro (tirzepatide). Covers interaction mechanisms, dose-separation timing, glucose effects, and monitoring recommendations.
Evidence-based guide on combining omega-3 fatty acids (EPA/DHA) with Mounjaro (tirzepatide). Covers interaction mechanisms, safety data, dose timing, monitoring, and clinical recommendations.
Is resveratrol safe to take with Mounjaro (tirzepatide)? Review the pharmacokinetic and pharmacodynamic interaction data, CYP3A4 concerns, dose-separation guidance, and monitoring recommendations.
St. John's Wort is a potent CYP3A4 inducer that could theoretically alter tirzepatide metabolism. Here's what the pharmacology actually shows, what to monitor, and when to talk to your prescriber.
Evidence-based guide on combining glycine with NMN or NR supplements. Covers interaction mechanisms, dose timing, safety data, and monitoring advice from clinical research.
No direct pharmacokinetic interaction exists between L-theanine and NMN or NR. Learn about mechanism overlap, dose timing, monitoring, and what the clinical evidence actually shows.
Evidence-based guide to combining quercetin with NMN or NR (nicotinamide mononucleotide/riboside). Covers pharmacokinetic interactions, CYP3A4 effects, dose timing, monitoring, and clinical recommendations.
Evidence-based guide on combining resveratrol with NMN (nicotinamide mononucleotide) or NR (nicotinamide riboside). Covers pharmacokinetic interactions, CYP3A4 considerations, dose timing, and monitoring recommendations.
Evidence-based guide to combining turmeric (curcumin) with NMN or nicotinamide riboside. Covers interaction mechanisms, dose-separation timing, monitoring, and safety data.
Evidence-based guide on combining vitamin B6 (pyridoxine) with NMN or nicotinamide riboside. Covers interaction mechanisms, neuropathy risk at high doses, dose-separation windows, and monitoring recommendations.
Evidence-based guide on combining 5-HTP supplements with oral micronized progesterone (Prometrium). Covers interaction mechanisms, safety data, dose-separation strategies, and monitoring recommendations.
Evidence-based guide on combining alpha-lipoic acid (ALA) with oral micronized progesterone (Prometrium). Covers interaction mechanisms, dose-separation strategies, monitoring, and clinical safety data.
Evidence-based guide on combining calcium supplements with oral micronized progesterone (Prometrium). Covers interaction risk, dose-separation timing, monitoring, and clinical recommendations.
Evidence-based guide on combining folate supplements with oral micronized progesterone (Prometrium). Covers interaction mechanisms, MTHFR considerations, dosing, and monitoring.
Evidence-based guide to the interaction between EGCG / green tea extract and oral micronized progesterone (Prometrium), covering CYP3A4 pharmacokinetics, hepatotoxicity risk, dose-separation windows, and monitoring.
Evidence-based guide on combining NAC supplements with oral micronized progesterone (Prometrium). Covers pharmacokinetic interactions, dose timing, monitoring, and clinical safety data.
Evidence-based guide on taking zinc supplements with oral micronized progesterone. Covers interaction mechanisms, dose-separation timing, monitoring, and clinical recommendations.
Berberine may interact with low-dose oral minoxidil through CYP3A4 inhibition and additive blood pressure lowering. Learn the risks, dose-separation strategies, and monitoring steps.
Learn whether caffeine interacts with low-dose oral minoxidil for hair loss, including pharmacokinetic and pharmacodynamic considerations, dose-separation guidance, and monitoring recommendations.
Evidence-based guide on combining glutathione supplements with low-dose oral minoxidil for hair loss, covering pharmacokinetic interactions, liver metabolism, safety data, and clinical monitoring recommendations.
Evidence-based guide to the turmeric/curcumin and oral minoxidil interaction, covering pharmacokinetic mechanisms, blood pressure effects, anticoagulant overlap, dose-separation strategies, and monitoring recommendations.
Creatine and Ozempic (semaglutide) have no direct drug interaction, but creatine can raise serum creatinine and confuse kidney monitoring. Here is what clinicians recommend.
Evidence-based guide on taking magnesium supplements with Ozempic (semaglutide 0.5 to 2.0 mg). Covers drug-supplement interactions, dose timing, monitoring, and clinical recommendations.
Evidence-based guide on taking vitamin B6 with Ozempic. Covers interaction risk, safe dosing, neuropathy concerns, monitoring, and clinical recommendations for semaglutide users.
Evidence-based guide on combining L-theanine with pioglitazone (Actos). Covers pharmacokinetic and pharmacodynamic interactions, dose-separation windows, monitoring, and clinical guidance.
Evidence-based guide on combining magnesium supplements with pioglitazone (Actos). Covers interaction risk, insulin sensitivity effects, dose timing, and monitoring recommendations.
Evidence-based guide on combining omega-3 fatty acids (EPA/DHA) with pioglitazone (Actos). Covers drug-supplement interactions, safety data, monitoring, and clinical recommendations.
Berberine may raise Prometrium blood levels by inhibiting CYP3A4. Learn the pharmacokinetic interaction, dose-separation strategy, monitoring labs, and what to tell your prescriber.
A clinical look at whether lion's mane mushroom is safe alongside Prometrium (micronized progesterone), covering interaction mechanisms, dose-separation strategies, and monitoring guidance.
Evidence-based guide on combining melatonin with Prometrium (micronized progesterone). Covers pharmacokinetic and pharmacodynamic interactions, dose-separation strategies, monitoring, and clinical recommendations.
Clinical review of berberine and bremelanotide (PT-141) co-use, covering CYP3A4 inhibition, blood pressure interactions, dose-separation strategy, and monitoring guidance.
Evidence-based guide on combining CoQ10 supplements with PT-141 (bremelanotide). Covers pharmacokinetic and pharmacodynamic interactions, dose-separation strategies, blood pressure monitoring, and clinical guidance for safe co-administration.
Evidence-based guide on reishi mushroom and PT-141 (bremelanotide) interactions, covering pharmacokinetic and pharmacodynamic concerns, dose-separation strategies, and monitoring recommendations.
Evidence-based guide on taking rhodiola rosea with PT-141 (bremelanotide). Covers pharmacokinetic and pharmacodynamic interaction risks, dose-separation strategies, monitoring parameters, and what to do if you already use both.
St. John's Wort is a potent CYP3A4 inducer that may reduce bremelanotide exposure. Learn about the pharmacokinetic interaction, dose-separation options, monitoring, and what to do if you already take both.
A clinical review of the ashwagandha-rapamycin interaction, covering CYP3A4 metabolism, immune overlap, and what needs pharmacist or transplant-team verification before combining them.
Berberine inhibits CYP3A4, the same enzyme that metabolizes sirolimus. Learn about the pharmacokinetic interaction, dose-separation strategies, and monitoring requirements before combining these two compounds.
Evidence-based guide on glycine and rapamycin (sirolimus) interactions, covering pharmacokinetic overlap, sleep effects, glycemic impact, dose-separation strategies, and monitoring protocols.
Evidence-based guide to the interaction between green tea extract / EGCG and rapamycin (sirolimus), covering CYP3A4 metabolism, hepatotoxicity risk, dose-separation strategies, and monitoring recommendations.
Evidence-based guide to combining L-theanine and rapamycin (sirolimus). Covers pharmacokinetic and pharmacodynamic interactions, dose-separation strategies, monitoring, and clinical guidance.
Evidence-based guide on taking magnesium supplements with rapamycin (sirolimus). Covers pharmacokinetic interactions, dose-separation timing, monitoring needs, and clinical recommendations.
Quercetin inhibits CYP3A4 and P-glycoprotein, two pathways rapamycin depends on for clearance. Learn the interaction mechanism, monitoring requirements, and dose-separation strategies.
Evidence-based guide on the interaction between turmeric (curcumin) and rapamycin (sirolimus), covering CYP3A4 inhibition, pharmacokinetic risks, dose-separation strategies, and monitoring recommendations.
What is known and not established about combining omega-3 fish oil (EPA/DHA) with Rezdiffra (resmetirom) for MASH, including monitoring guidance and open questions requiring pharmacist or clinician verification.
Understand creatine with rosuvastatin: what muscle studies show, how kidney tests can change, and which symptoms need medical assessment.
Separate the aluminum-magnesium antacid timing instruction from magnesium-only evidence using the product label and two different study outcomes.
Evidence-based guide on combining omega-3 fish oil supplements with rosuvastatin (Crestor). Covers drug interactions, clinical trial data, dosing, monitoring, and when to talk to your prescriber.
Evidence-based guide to taking rhodiola rosea with rosuvastatin (Crestor). Covers pharmacokinetic and pharmacodynamic interaction risks, dose-separation strategies, monitoring, and what to do if you already take both.
Yes, you can take vitamin B12 with rosuvastatin (Crestor). No known interaction, no dose separation needed. Metformin, not statins, depletes B12 over time.